Global Implantable Drug Eluting Balloon Market Growth 2026-2032
The global Implantable Drug Eluting Balloon market size is predicted to grow from US$ 937 million in 2025 to US$ 2264 million in 2032; it is expected to grow at a CAGR of 13.7% from 2026 to 2032.
Implantable Drug-Eluting Balloon is a medical device used to treat narrowed or blocked blood vessels, particularly in coronary and peripheral arteries. The balloon is coated with a therapeutic drug that is released directly to the artery wall when the balloon inflates. This drug helps prevent restenosis, or re-narrowing of the artery, by inhibiting cell proliferation. Drug-eluting balloons are commonly used in minimally invasive procedures as an alternative to stents, especially in complex cases where stents may not be suitable.
United States market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Implantable Drug Eluting Balloon players cover B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Implantable Drug Eluting Balloon Industry Forecast” looks at past sales and reviews total world Implantable Drug Eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Implantable Drug Eluting Balloon sales for 2026 through 2032. With Implantable Drug Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Drug Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Implantable Drug Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Drug Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Drug Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Drug Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Drug Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Drug Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Implantable Drug Eluting Balloon market?
What factors are driving Implantable Drug Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Drug Eluting Balloon market opportunities vary by end market size?
How does Implantable Drug Eluting Balloon break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Implantable Drug-Eluting Balloon is a medical device used to treat narrowed or blocked blood vessels, particularly in coronary and peripheral arteries. The balloon is coated with a therapeutic drug that is released directly to the artery wall when the balloon inflates. This drug helps prevent restenosis, or re-narrowing of the artery, by inhibiting cell proliferation. Drug-eluting balloons are commonly used in minimally invasive procedures as an alternative to stents, especially in complex cases where stents may not be suitable.
United States market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Implantable Drug Eluting Balloon is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Implantable Drug Eluting Balloon players cover B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Implantable Drug Eluting Balloon Industry Forecast” looks at past sales and reviews total world Implantable Drug Eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Implantable Drug Eluting Balloon sales for 2026 through 2032. With Implantable Drug Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Drug Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Implantable Drug Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Drug Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Drug Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Drug Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Drug Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Drug Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peripheral DEBs
- Coronary DEBs
- Catheterization Laboratory
- Hospital
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotech
- Philips
- Eurocor
- Aachen Resonance
- Biotronic
What is the 10-year outlook for the global Implantable Drug Eluting Balloon market?
What factors are driving Implantable Drug Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Drug Eluting Balloon market opportunities vary by end market size?
How does Implantable Drug Eluting Balloon break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Drug Eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Implantable Drug Eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Implantable Drug Eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Implantable Drug Eluting Balloon Segment by Type
2.2.1 Peripheral DEBs
2.2.2 Coronary DEBs
2.2.3 Implantable Drug Eluting Balloon Sales by Type
2.2.3.1 Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Implantable Drug Eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Implantable Drug Eluting Balloon Sale Price by Type (2021-2026)
2.3 Implantable Drug Eluting Balloon Segment by Application
2.3.1 Catheterization Laboratory
2.3.2 Hospital
2.3.3 Other
2.3.4 Implantable Drug Eluting Balloon Sales by Application
2.3.4.1 Global Implantable Drug Eluting Balloon Sale Market Share by Application (2021-2026)
2.3.4.2 Global Implantable Drug Eluting Balloon Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Implantable Drug Eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Implantable Drug Eluting Balloon Breakdown Data by Company
3.1.1 Global Implantable Drug Eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Implantable Drug Eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Implantable Drug Eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Implantable Drug Eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Implantable Drug Eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Implantable Drug Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Implantable Drug Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Drug Eluting Balloon Product Location Distribution
3.4.2 Players Implantable Drug Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE DRUG ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Implantable Drug Eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Implantable Drug Eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Implantable Drug Eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Implantable Drug Eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Implantable Drug Eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Implantable Drug Eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Implantable Drug Eluting Balloon Sales Growth
4.4 APAC Implantable Drug Eluting Balloon Sales Growth
4.5 Europe Implantable Drug Eluting Balloon Sales Growth
4.6 Middle East & Africa Implantable Drug Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Implantable Drug Eluting Balloon Sales by Country
5.1.1 Americas Implantable Drug Eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Implantable Drug Eluting Balloon Sales by Type (2021-2026)
5.3 Americas Implantable Drug Eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Drug Eluting Balloon Sales by Region
6.1.1 APAC Implantable Drug Eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Implantable Drug Eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Implantable Drug Eluting Balloon Sales by Type (2021-2026)
6.3 APAC Implantable Drug Eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Drug Eluting Balloon by Country
7.1.1 Europe Implantable Drug Eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Implantable Drug Eluting Balloon Sales by Type (2021-2026)
7.3 Europe Implantable Drug Eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Drug Eluting Balloon by Country
8.1.1 Middle East & Africa Implantable Drug Eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Implantable Drug Eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Implantable Drug Eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Drug Eluting Balloon
10.3 Manufacturing Process Analysis of Implantable Drug Eluting Balloon
10.4 Industry Chain Structure of Implantable Drug Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Drug Eluting Balloon Distributors
11.3 Implantable Drug Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE DRUG ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Implantable Drug Eluting Balloon Market Size Forecast by Region
12.1.1 Global Implantable Drug Eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Implantable Drug Eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Implantable Drug Eluting Balloon Forecast by Type (2027-2032)
12.7 Global Implantable Drug Eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.1.3 B. Braun Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.3.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.4.3 BD Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotech
13.5.1 Yinyi Biotech Company Information
13.5.2 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.5.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotech Main Business Overview
13.5.5 Yinyi Biotech Latest Developments
13.6 Philips
13.6.1 Philips Company Information
13.6.2 Philips Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.6.3 Philips Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Philips Main Business Overview
13.6.5 Philips Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.7.3 Eurocor Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 Aachen Resonance
13.8.1 Aachen Resonance Company Information
13.8.2 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Aachen Resonance Main Business Overview
13.8.5 Aachen Resonance Latest Developments
13.9 Biotronic
13.9.1 Biotronic Company Information
13.9.2 Biotronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biotronic Main Business Overview
13.9.5 Biotronic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Drug Eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Implantable Drug Eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Implantable Drug Eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Implantable Drug Eluting Balloon Segment by Type
2.2.1 Peripheral DEBs
2.2.2 Coronary DEBs
2.2.3 Implantable Drug Eluting Balloon Sales by Type
2.2.3.1 Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Implantable Drug Eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Implantable Drug Eluting Balloon Sale Price by Type (2021-2026)
2.3 Implantable Drug Eluting Balloon Segment by Application
2.3.1 Catheterization Laboratory
2.3.2 Hospital
2.3.3 Other
2.3.4 Implantable Drug Eluting Balloon Sales by Application
2.3.4.1 Global Implantable Drug Eluting Balloon Sale Market Share by Application (2021-2026)
2.3.4.2 Global Implantable Drug Eluting Balloon Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Implantable Drug Eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Implantable Drug Eluting Balloon Breakdown Data by Company
3.1.1 Global Implantable Drug Eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Implantable Drug Eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Implantable Drug Eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Implantable Drug Eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Implantable Drug Eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Implantable Drug Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Implantable Drug Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Drug Eluting Balloon Product Location Distribution
3.4.2 Players Implantable Drug Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE DRUG ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Implantable Drug Eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Implantable Drug Eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Implantable Drug Eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Implantable Drug Eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Implantable Drug Eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Implantable Drug Eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Implantable Drug Eluting Balloon Sales Growth
4.4 APAC Implantable Drug Eluting Balloon Sales Growth
4.5 Europe Implantable Drug Eluting Balloon Sales Growth
4.6 Middle East & Africa Implantable Drug Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Implantable Drug Eluting Balloon Sales by Country
5.1.1 Americas Implantable Drug Eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Implantable Drug Eluting Balloon Sales by Type (2021-2026)
5.3 Americas Implantable Drug Eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Drug Eluting Balloon Sales by Region
6.1.1 APAC Implantable Drug Eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Implantable Drug Eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Implantable Drug Eluting Balloon Sales by Type (2021-2026)
6.3 APAC Implantable Drug Eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Drug Eluting Balloon by Country
7.1.1 Europe Implantable Drug Eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Implantable Drug Eluting Balloon Sales by Type (2021-2026)
7.3 Europe Implantable Drug Eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Drug Eluting Balloon by Country
8.1.1 Middle East & Africa Implantable Drug Eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Implantable Drug Eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Implantable Drug Eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Implantable Drug Eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Drug Eluting Balloon
10.3 Manufacturing Process Analysis of Implantable Drug Eluting Balloon
10.4 Industry Chain Structure of Implantable Drug Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Drug Eluting Balloon Distributors
11.3 Implantable Drug Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE DRUG ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Implantable Drug Eluting Balloon Market Size Forecast by Region
12.1.1 Global Implantable Drug Eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Implantable Drug Eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Implantable Drug Eluting Balloon Forecast by Type (2027-2032)
12.7 Global Implantable Drug Eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.1.3 B. Braun Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.3.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.4.3 BD Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotech
13.5.1 Yinyi Biotech Company Information
13.5.2 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.5.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotech Main Business Overview
13.5.5 Yinyi Biotech Latest Developments
13.6 Philips
13.6.1 Philips Company Information
13.6.2 Philips Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.6.3 Philips Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Philips Main Business Overview
13.6.5 Philips Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.7.3 Eurocor Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 Aachen Resonance
13.8.1 Aachen Resonance Company Information
13.8.2 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Aachen Resonance Main Business Overview
13.8.5 Aachen Resonance Latest Developments
13.9 Biotronic
13.9.1 Biotronic Company Information
13.9.2 Biotronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
13.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biotronic Main Business Overview
13.9.5 Biotronic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Implantable Drug Eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Implantable Drug Eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEBs
Table 4. Major Players of Coronary DEBs
Table 5. Global Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Implantable Drug Eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Implantable Drug Eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Implantable Drug Eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 11. Global Implantable Drug Eluting Balloon Sale Market Share by Application (2021-2026)
Table 12. Global Implantable Drug Eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 13. Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2026)
Table 14. Global Implantable Drug Eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Implantable Drug Eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 16. Global Implantable Drug Eluting Balloon Sales Market Share by Company (2021-2026)
Table 17. Global Implantable Drug Eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Implantable Drug Eluting Balloon Revenue Market Share by Company (2021-2026)
Table 19. Global Implantable Drug Eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Implantable Drug Eluting Balloon Producing Area Distribution and Sales Area
Table 21. Players Implantable Drug Eluting Balloon Products Offered
Table 22. Implantable Drug Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Implantable Drug Eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Implantable Drug Eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 27. Global Implantable Drug Eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Implantable Drug Eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Implantable Drug Eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 31. Global Implantable Drug Eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Implantable Drug Eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 34. Americas Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2026)
Table 35. Americas Implantable Drug Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 37. Americas Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 38. APAC Implantable Drug Eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 39. APAC Implantable Drug Eluting Balloon Sales Market Share by Region (2021-2026)
Table 40. APAC Implantable Drug Eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 42. APAC Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 43. Europe Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 44. Europe Implantable Drug Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 46. Europe Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Implantable Drug Eluting Balloon
Table 52. Key Market Challenges & Risks of Implantable Drug Eluting Balloon
Table 53. Key Industry Trends of Implantable Drug Eluting Balloon
Table 54. Implantable Drug Eluting Balloon Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Implantable Drug Eluting Balloon Distributors List
Table 57. Implantable Drug Eluting Balloon Customer List
Table 58. Global Implantable Drug Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Implantable Drug Eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Implantable Drug Eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Implantable Drug Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Implantable Drug Eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Implantable Drug Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Implantable Drug Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Implantable Drug Eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Implantable Drug Eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Implantable Drug Eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Implantable Drug Eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. B. Braun Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 73. B. Braun Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 74. B. Braun Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. B. Braun Main Business
Table 76. B. Braun Latest Developments
Table 77. Medtronic Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 78. Medtronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 79. Medtronic Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Medtronic Main Business
Table 81. Medtronic Latest Developments
Table 82. Boston Scientific Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 83. Boston Scientific Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 84. Boston Scientific Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Boston Scientific Main Business
Table 86. Boston Scientific Latest Developments
Table 87. BD Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 88. BD Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 89. BD Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. BD Main Business
Table 91. BD Latest Developments
Table 92. Yinyi Biotech Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 93. Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 94. Yinyi Biotech Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yinyi Biotech Main Business
Table 96. Yinyi Biotech Latest Developments
Table 97. Philips Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 98. Philips Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 99. Philips Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Philips Main Business
Table 101. Philips Latest Developments
Table 102. Eurocor Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 103. Eurocor Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 104. Eurocor Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Eurocor Main Business
Table 106. Eurocor Latest Developments
Table 107. Aachen Resonance Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 108. Aachen Resonance Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 109. Aachen Resonance Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Aachen Resonance Main Business
Table 111. Aachen Resonance Latest Developments
Table 112. Biotronic Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 113. Biotronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 114. Biotronic Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Biotronic Main Business
Table 116. Biotronic Latest Developments
Table 1. Implantable Drug Eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Implantable Drug Eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEBs
Table 4. Major Players of Coronary DEBs
Table 5. Global Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Implantable Drug Eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Implantable Drug Eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Implantable Drug Eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 11. Global Implantable Drug Eluting Balloon Sale Market Share by Application (2021-2026)
Table 12. Global Implantable Drug Eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 13. Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2026)
Table 14. Global Implantable Drug Eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Implantable Drug Eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 16. Global Implantable Drug Eluting Balloon Sales Market Share by Company (2021-2026)
Table 17. Global Implantable Drug Eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Implantable Drug Eluting Balloon Revenue Market Share by Company (2021-2026)
Table 19. Global Implantable Drug Eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Implantable Drug Eluting Balloon Producing Area Distribution and Sales Area
Table 21. Players Implantable Drug Eluting Balloon Products Offered
Table 22. Implantable Drug Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Implantable Drug Eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Implantable Drug Eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 27. Global Implantable Drug Eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Implantable Drug Eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Implantable Drug Eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 31. Global Implantable Drug Eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Implantable Drug Eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 34. Americas Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2026)
Table 35. Americas Implantable Drug Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 37. Americas Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 38. APAC Implantable Drug Eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 39. APAC Implantable Drug Eluting Balloon Sales Market Share by Region (2021-2026)
Table 40. APAC Implantable Drug Eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 42. APAC Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 43. Europe Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 44. Europe Implantable Drug Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 46. Europe Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Implantable Drug Eluting Balloon
Table 52. Key Market Challenges & Risks of Implantable Drug Eluting Balloon
Table 53. Key Industry Trends of Implantable Drug Eluting Balloon
Table 54. Implantable Drug Eluting Balloon Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Implantable Drug Eluting Balloon Distributors List
Table 57. Implantable Drug Eluting Balloon Customer List
Table 58. Global Implantable Drug Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Implantable Drug Eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Implantable Drug Eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Implantable Drug Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Implantable Drug Eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Implantable Drug Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Implantable Drug Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Implantable Drug Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Implantable Drug Eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Implantable Drug Eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Implantable Drug Eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Implantable Drug Eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. B. Braun Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 73. B. Braun Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 74. B. Braun Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. B. Braun Main Business
Table 76. B. Braun Latest Developments
Table 77. Medtronic Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 78. Medtronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 79. Medtronic Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Medtronic Main Business
Table 81. Medtronic Latest Developments
Table 82. Boston Scientific Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 83. Boston Scientific Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 84. Boston Scientific Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Boston Scientific Main Business
Table 86. Boston Scientific Latest Developments
Table 87. BD Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 88. BD Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 89. BD Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. BD Main Business
Table 91. BD Latest Developments
Table 92. Yinyi Biotech Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 93. Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 94. Yinyi Biotech Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yinyi Biotech Main Business
Table 96. Yinyi Biotech Latest Developments
Table 97. Philips Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 98. Philips Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 99. Philips Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Philips Main Business
Table 101. Philips Latest Developments
Table 102. Eurocor Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 103. Eurocor Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 104. Eurocor Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Eurocor Main Business
Table 106. Eurocor Latest Developments
Table 107. Aachen Resonance Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 108. Aachen Resonance Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 109. Aachen Resonance Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Aachen Resonance Main Business
Table 111. Aachen Resonance Latest Developments
Table 112. Biotronic Basic Information, Implantable Drug Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 113. Biotronic Implantable Drug Eluting Balloon Product Portfolios and Specifications
Table 114. Biotronic Implantable Drug Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Biotronic Main Business
Table 116. Biotronic Latest Developments
LIST OF FIGURES
Figure 1. Picture of Implantable Drug Eluting Balloon
Figure 2. Implantable Drug Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Drug Eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Implantable Drug Eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Implantable Drug Eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEBs
Figure 12. Product Picture of Coronary DEBs
Figure 13. Global Implantable Drug Eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Implantable Drug Eluting Balloon Consumed in Catheterization Laboratory
Figure 16. Global Implantable Drug Eluting Balloon Market: Catheterization Laboratory (2021-2026) & (K Units)
Figure 17. Implantable Drug Eluting Balloon Consumed in Hospital
Figure 18. Global Implantable Drug Eluting Balloon Market: Hospital (2021-2026) & (K Units)
Figure 19. Implantable Drug Eluting Balloon Consumed in Other
Figure 20. Global Implantable Drug Eluting Balloon Market: Other (2021-2026) & (K Units)
Figure 21. Global Implantable Drug Eluting Balloon Sale Market Share by Application (2025)
Figure 22. Global Implantable Drug Eluting Balloon Revenue Market Share by Application in 2026
Figure 23. Implantable Drug Eluting Balloon Sales by Company in 2026 (K Units)
Figure 24. Global Implantable Drug Eluting Balloon Sales Market Share by Company in 2026
Figure 25. Implantable Drug Eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 26. Global Implantable Drug Eluting Balloon Revenue Market Share by Company in 2026
Figure 27. Global Implantable Drug Eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Implantable Drug Eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 30. Americas Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 31. APAC Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 32. APAC Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 33. Europe Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 34. Europe Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 37. Americas Implantable Drug Eluting Balloon Sales Market Share by Country in 2026
Figure 38. Americas Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 39. Americas Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 40. Americas Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 41. United States Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Implantable Drug Eluting Balloon Sales Market Share by Region in 2026
Figure 46. APAC Implantable Drug Eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 47. APAC Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 48. APAC Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 49. China Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. India Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Implantable Drug Eluting Balloon Sales Market Share by Country in 2026
Figure 57. Europe Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 58. Europe Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 59. Europe Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 60. Germany Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. France Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 68. Egypt Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Implantable Drug Eluting Balloon in 2026
Figure 74. Manufacturing Process Analysis of Implantable Drug Eluting Balloon
Figure 75. Industry Chain Structure of Implantable Drug Eluting Balloon
Figure 76. Channels of Distribution
Figure 77. Global Implantable Drug Eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 78. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Implantable Drug Eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Implantable Drug Eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Implantable Drug Eluting Balloon
Figure 2. Implantable Drug Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Drug Eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Implantable Drug Eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Implantable Drug Eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Implantable Drug Eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEBs
Figure 12. Product Picture of Coronary DEBs
Figure 13. Global Implantable Drug Eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Implantable Drug Eluting Balloon Consumed in Catheterization Laboratory
Figure 16. Global Implantable Drug Eluting Balloon Market: Catheterization Laboratory (2021-2026) & (K Units)
Figure 17. Implantable Drug Eluting Balloon Consumed in Hospital
Figure 18. Global Implantable Drug Eluting Balloon Market: Hospital (2021-2026) & (K Units)
Figure 19. Implantable Drug Eluting Balloon Consumed in Other
Figure 20. Global Implantable Drug Eluting Balloon Market: Other (2021-2026) & (K Units)
Figure 21. Global Implantable Drug Eluting Balloon Sale Market Share by Application (2025)
Figure 22. Global Implantable Drug Eluting Balloon Revenue Market Share by Application in 2026
Figure 23. Implantable Drug Eluting Balloon Sales by Company in 2026 (K Units)
Figure 24. Global Implantable Drug Eluting Balloon Sales Market Share by Company in 2026
Figure 25. Implantable Drug Eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 26. Global Implantable Drug Eluting Balloon Revenue Market Share by Company in 2026
Figure 27. Global Implantable Drug Eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Implantable Drug Eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 30. Americas Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 31. APAC Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 32. APAC Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 33. Europe Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 34. Europe Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Implantable Drug Eluting Balloon Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Implantable Drug Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 37. Americas Implantable Drug Eluting Balloon Sales Market Share by Country in 2026
Figure 38. Americas Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 39. Americas Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 40. Americas Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 41. United States Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Implantable Drug Eluting Balloon Sales Market Share by Region in 2026
Figure 46. APAC Implantable Drug Eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 47. APAC Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 48. APAC Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 49. China Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. India Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Implantable Drug Eluting Balloon Sales Market Share by Country in 2026
Figure 57. Europe Implantable Drug Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 58. Europe Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 59. Europe Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 60. Germany Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. France Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 68. Egypt Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Implantable Drug Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Implantable Drug Eluting Balloon in 2026
Figure 74. Manufacturing Process Analysis of Implantable Drug Eluting Balloon
Figure 75. Industry Chain Structure of Implantable Drug Eluting Balloon
Figure 76. Channels of Distribution
Figure 77. Global Implantable Drug Eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 78. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Implantable Drug Eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Implantable Drug Eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Implantable Drug Eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
